Medical Biotechnology — Current Affairs 2026

Current Affairs Connections

Recent developments and news linked to Medical Biotechnology.

DBT-BIRAC Launches New Initiatives to Boost Biomanufacturing and Biotech Startups

Early 2024

The Department of Biotechnology (DBT) and its arm, BIRAC, have announced several new funding calls and incubation programs aimed at strengthening India's biomanufacturing capabilities and supporting early-stage biotechnology startups. These initiatives focus on areas like synthetic biology, advanced diagnostics, and sustainable bioprocesses. The goal is to create a robust ecosystem for innovation, translating research into marketable products, and fostering a skilled workforce. This is a direct continuation of the National Biotechnology Development Strategy's objectives.

UPSC Angle: Relevant for Mains (GS-III Science & Technology, Economy) and Prelims. It showcases government's proactive role in promoting biotechnology, the importance of public-private partnerships (BIRAC model), and the focus on indigenous innovation. Aspirants should be aware of specific schemes and their impact on the biotech sector, particularly in job creation and economic growth.

Background (2023)

Earlier events that provide context for this topic.

India Approves First Indigenous CAR-T Cell Therapy for Cancer Treatment

October 2023

In a landmark development, the Central Drugs Standard Control Organization (CDSCO) granted market authorization for NexCAR19, India's first indigenously developed CAR-T cell therapy, for relapsed/refractory B-cell lymphomas and leukemia. Developed by ImmunoACT, an IIT Bombay incubated company, this approval signifies India's growing prowess in advanced cell and gene therapies. It offers a new, potentially curative option for patients who have exhausted other treatments, while also being significantly more affordable than imported alternatives. This aligns with the 'Make in India' initiative in high-tech healthcare.

UPSC Angle: This event is crucial for Mains (GS-III Science & Technology, GS-II Health) and Prelims. It highlights India's self-reliance in advanced medical technology, the role of academic innovation (IIT Bombay), and the regulatory approval process for cutting-edge therapies. Questions could focus on the mechanism of CAR-T, its significance for cancer treatment in India, and the challenges of affordability and accessibility.